Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ubiquitin–proteasome system (UPS) is the principal pathway for regulated protein degradation in eukaryotic cells. It is essential for maintaining cellular homeostasis by selectively degrading misfolded, damaged, or regulatory proteins and thus controls numerous cellular processes including cell cycle progression, signal transduction, and stress responses. The UPS involves ubiquitin tagging of target proteins by E1, E2, and E3 enzymes, followed by recognition and degradation by the 26S proteasome.
Inhibition of proteasome activity, leading to accumulation of polyubiquitinated proteins and cell death, particularly in cancer cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin–Proteasome System (UPS).